Metabolic surgery for body mass index (BMI) < 27 kg/m2 patients with type 2 diabetes mellitus
ISRCTN | ISRCTN56897851 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN56897851 |
Secondary identifying numbers | EMRP-099-084 |
- Submission date
- 06/10/2011
- Registration date
- 18/10/2011
- Last edited
- 27/11/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Plain English summary of protocol
Background and study aims:
Type 2 diabetes mellitus (T2DM) is a disease with high mortality rates. It is the most common endocrine disorder worldwide. People with diabetes are at increased risk of cardiovascular diseases. The current treatment includes diet control, exercise, and use of anti-diabetic meditations. However, recent evidence suggests surgery can reduce the symptoms of T2DM, especially in morbidly obese patients. The aim of our study is to evaluate the effectiveness and safety Laparoscopic Roux-en-Y gastric Bypass (LRYGB) surgery in non obeseT2DM patients.
Who can participate?
Either male or female patients aged 18 - 65 years, with a Body Mass Index (BMI) of less than 27 kg/m2. Participants should also be diagnosed with T2DM for at least 6 months.
What does the study involve?
Laparoscopic Roux-en-Y gastric Bypass (LRYGB) surgery.
What are the possible benefits and risks of participating?
Patients may experience reduced symptoms of T2DM, however there is the risk that there maybe complications from the surgery.
Where is the study run from?
EDa Hospital, Taiwan
When is the study starting and how long is it expected to run for?
The study started in June 2009 and ended in May 2011.
Who is funding the study?
EDa Hospital, Taiwan
Who is the main contact?
Professor Chih-Kun Huang
dr.ckhuang@hotmail.com
Contact information
Scientific
1 E-Da Road
Jian-Shu Tsuen
Yan-Chau Shiang
Kaohsiung
824
Taiwan
dr.ckhuang@hotmail.com |
Study information
Study design | Pilot study |
---|---|
Primary study design | Interventional |
Secondary study design | Non randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please contact Professor Chih-Kun Huang at dr.ckhuang@hotmail.com to request a patient information sheet |
Scientific title | Metabolic surgery for body mass index (BMI) < 27 kg/m2 patients with type 2 diabetes mellitus: early results |
Study acronym | BMI |
Study objectives | To see the effect of Surgery Laparoscopic Roux-en-Y Gastric bypass (LRYGB) on type 2 diabetes mellitus (T2DM) status on patients with BMI < 27kg/m2 |
Ethics approval(s) | The ethics committee and Institutional Review Board of the E-Da Hospital, 11 December 2008, ref: EMRP- 097-106 |
Health condition(s) or problem(s) studied | Type 2 diabetes Mellitus |
Intervention | Surgery, Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) |
Intervention type | Other |
Primary outcome measure | 1. Remission of T2DM, defined by HbA1c < 6.5% without oral hypoglycemic drugs or insulin 2. Glycemic control, defined as HbA1C of < 7 % despite no use of anti-diabetic medications 3. Improvement of T2DM, defined as a reduction of at least 25% in the fasting plasma glucose level and/ or at least 1% in the pre-operative HbA1c level with hypoglycemic drug treatment 4. Failure of surgical procedure, defined as no significant improvement or worsened if a patient required an additional anti-diabetic meditation |
Secondary outcome measures | 1. Resolution of co-morbities 2. Complications related to procedure |
Overall study start date | 01/06/2009 |
Completion date | 31/05/2011 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Upper age limit | 65 Years |
Sex | Both |
Target number of participants | 21 |
Key inclusion criteria | 1. Age 18-65 years 2. BMI < 27 kg/m2 3. Poorly controlled T2DM for at least 6 months with glycosylated haemoglobin (Hb A1C) level of >7.0% |
Key exclusion criteria | 1. Patients younger than 18 or older than 65 years 2. Those planning pregnancy in next 2 years 3. Patients with type 1 diabetes mellitus (T1DM) 4. Latent autoimmune diabetes in adults 5. Malignancy 6. Debilitating disease 7. Unresolved psychiatric illness 8. Substance abuse 9. American Society of Anesthesiologists (ASA) classification > III |
Date of first enrolment | 01/06/2009 |
Date of final enrolment | 31/05/2011 |
Locations
Countries of recruitment
- Taiwan
Study participating centre
824
Taiwan
Sponsor information
Hospital/treatment centre
1 Yida Road
Jiaosu Village
Yanchao District
Kaohsiung
82445
Taiwan
ed103221@edah.org.tw | |
Website | http://www.edah-hospital.com/en/index.html |
https://ror.org/00eh7f421 |
Funders
Funder type
Hospital/treatment centre
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |